Post-earnings recap
Reported
Thu, Nov 4, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Zimmer Biomet's earnings report shows a positive surprise in EPS, but the stock fell by 7.39% following the announcement. The decline may be attributed to concerns over supply chain issues and the lack of revenue data. Investors might be cautious as the company navigates these challenges without updated guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.81 | N/A | +3.19% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about external factors impacting performance. They emphasized their commitment to long-term growth strategies.
Management highlighted ongoing challenges in the supply chain.
They noted a focus on innovation and product development despite market pressures.